Federal Circuit backs Boston Scientific in stent clash
02-10-2017
Boston Scientific and Abbott caught up in patent claim
14-03-2017
Jan-Otto / iStockphoto.com
California-based FlexStent accused healthcare company Abbott Laboratories of infringing a stent patent earlier this week, with the filing of a lawsuit at the US District Court for the Central District of California.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Abbott Laboratories, FlexStent, medical devices, patent infringement, coronary stents, medical devices
